Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026Héloïse Lucaccioni, the European IVE group, Mark Hamilton et al.|Eurosurveillance|2026Cited by 7
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025Angela Rose, European IVE group, Héloïse Lucaccioni et al.|Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)|2025Cited by 0